The journey from one Paralympics to another isn't easy. That was especially true from Tokyo to Paris, with an atypical three-year gap between Games due to the COVID-19 pandemic pushing back the former ...
If you are following Adaptive Biotechnologies (ADPT), the news that its collaboration and license agreement with Genentech is ending might catch your eye. The two biotech firms will wind down their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback